In summary, due to the crucial regulatory role of the CSF-1/CSF-1R signaling pathway in tumor development and fibrotic processes, inhibiting the CSF-1/CSF-1R signaling pathway seems to be a promising strategy for cancer treatment and fibrosis (Figure 1). This evidence concerns the gene CSF1 and cancer.